Cellin Technologies has the manufacturing authorization for investigational cell therapy medicinal products in the European Union. This authorization is issued by the Estonian State Agency of Medicines.

​

Cellin Technologies has also a specialized medical licence for providing laboratorial services from the Estonian Health Board and an activity licence for the handling of cells, tissues, and organs from the Estonian State Agency of Medicines.